- ABOUT IDF
- ABOUT PRIMARY
- Patient Insurance Center
- Bill of Rights for Patients with PIDD
- Patient Education Programs
- Peer Support
- Health Insurance FAQ’s
- Scholarship Programs
- USIDNET Patients
- IDF SCID Initiative
- Get Connected with IDF!
- IDF NEMO Initiative
- Clinical Trial Information
- Locate a Physician
- Ask IDF
- Volunteer for IDF
- IDF eHealthRecord
- IDF Kids Connection
- IDF Medical Advisory Committee
- IDF Nurse Advisory Committee
- Consulting Immunologist Program
- IDF & USIDNET LeBien Visiting Professor Program
- Continuing Education Course for Nurses
- Video Series For Nurses
- USIDNET Healthcare
- Health Insurance “How to Appeal” Tips
- Links to Professional Organization
- Healthcare Professional Contact
IDF Advocacy Center
The primary immunodeficiency patient community has unique needs with which most policymakers are not familiar. To help solve some of the problems that our community faces, IDF maintains a full-scale advocacy program focused on national and state healthcare issues.
Although the specific issues may change, the IDF advocacy program focuses on one main thing – Access to quality care. This includes access to all treatments, all sites of care, and specialists.
Please look at the links below to learn more about our Public Policy Campaigns and how you can become involved and join with us to make your voice heard through advocacy!
Our Advocacy Campaigns
IDF will periodically post status reports, links to other websites, and explanations of various provisions of the new health care reform law as well as implementation reports. Check out the webinar videos – Health Reform in Your Backyard
In January 2013, the Medicare IVIG Access Act (HR 1845) was signed into law by President Barrack Obama, creating a three-year demonstration project allowing for the payment of home infusion services for Medicare patients with PIDD to be implemented within one year of its signing.
Get the facts about the SCID Newborn Screening Campaign using the Newborn Screening Toolkit to become a successful advocate. Our goal is to have all states screen newborns for Severe Combined Immune Deficiency.
IDF advocates against harmful insurance preferred product formularies and policies for immunoglobulin replacement therapy. IDF believes that physicians, in consultation with their patients, should make decisions about changes in IVIG treatment as they are in the best position to understand the specific medical history and unique needs of each patient. Please inform IDF if your insurance plan is instituting a preferred product formulary for Ig therapy.
Policy Matters Blog:
IDF Advocacy Channel
The IDF Advocacy Channel videos communicate the powerful messages and stories of our patients to impact policy decisions. Focusing on patient advocacy on behalf of IDF public policy issues, this channel empowers the entire patient community. From those who share their personal stories to those who see others in similar situations standing up and making their voices heard, these videos tell powerful stories.
IDF needs you to share your story and be a part of this important effort. Contact us!